Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Gastrointestinal dysfunction is common in diabetic patients. In genetic (nonobese diabetic) and toxin-elicited (streptozotocin) models of diabetes in mice, we demonstrate defects in gastric emptying and nonadrenergic, noncholinergic relaxation of pyloric muscle, which resemble defects in mice harboring a deletion of the neuronal nitric oxide synthase gene (nNOS). The diabetic mice manifest pronounced reduction in pyloric nNOS protein and mRNA. The decline of nNOS in diabetic mice does not result from loss of myenteric neurons. nNOS expression and pyloric function are restored to normal levels by insulin treatment. Thus diabetic gastropathy in mice reflects an insulin-sensitive reversible loss of nNOS. In diabetic animals, delayed gastric emptying can be reversed with a phosphodiesterase inhibitor, sildenafil. These findings have implications for novel therapeutic approaches and may clarify the etiology of diabetic gastropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Insulin also restored the expression of neuronal nitric oxide synthase and GE in animal models of DM (63, 69).”
From Diabetic Gastroparesis. (2019) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
Oral Sildenafil in the Treatment of Erectile Dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382001 · Cited by 2,120
Targeted disruption of the neuronal nitric oxide synthase gene
Huang, P. L., Dawson, T. M., Bredt, D. S., Snyder, S. H., & Fishman, M. C. (1993) · Cell · doi:10.1016/0092-8674(93)90615-w · Cited by 1,303 · cited 3×
“A critical role for NO in gastropyloric function was established by the findings of pyloric hypertrophy and gastric dilation in mice harboring a targeted genomic deletion of neuronal nitric oxide synthase (nNOS–/–) (15).”
Self-citationSchaeren-Wiemers, N., & Gerfin-Moser, A. (1993) · Histochemistry · doi:10.1007/bf00267823 · Cited by 1,157
Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter
Bult, H., Boeckxstaens, G. E., Pelckmans, P. A., Jordaens, F. H., Maercke, Y. M. V., & Herman, A. G. (1990) · Nature · doi:10.1038/345346a0 · Cited by 993
Brodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
Delovitch, T. L., & Singh, B. (1997) · Immunity · doi:10.1016/s1074-7613(00)80392-1 · Cited by 676 · cited 1×
“Interestingly, in patients with recently diagnosed diabetes, some investigators have described accelerated gastric emptying (39, 55, 56).”
Disorders of gastrointestinal motility associated with diabetes mellitus
FELDMAN, M., & SCHILLER, L. R. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-3-378 · Cited by 653
Oral Sildenafil in the Treatment of Erectile Dysfunction
(1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390121 · Cited by 622
Research works printed but not linked: 2
- Porte, D., Jr., and Halter, J.B. 1999. The clinical syndrome of diabetes mellitus. In Diabetic neuropathy. P.J. Dyck and P.K. Thomas, editors. W.B. Saunders Co. Philadelphia, Pennsylvania, USA. 1-28.
- Malcolm, A., and Camilleri, M. 1999. Assessment of gastrointestinal function. In Diabetic neuropathy. P.J. Dyck and P.K. Thomas, editors. W.B. Saunders Co. Philadelphia, Pennsylvania, USA. 211-221.
Cited by
Parkman, H. P., Hasler, W. L., & Fisher, R. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.055 · Cited by 738
NO as a signalling molecule in the nervous system
Esplugues, J. V. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704569 · Cited by 545
“…hypertrophic pyloric stenosis has been attributed to a lack of NOS-containing nerves at the pylorus (Vanderwin- den et al., 1992) while diabetic gastropathy has been linked to a loss of nNOS that can be treated with insulin and the phosphodiesterase-5 inhibitor sildena®l (Watkins et al., 2000).”
BackgroundRelationships of Upper Gastrointestinal Motor and Sensory Function With Glycemic Control
Rayner, C. K., Samsom, M., Jones, K. L., & Horowitz, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.371 · Cited by 460
Cellular Changes in Diabetic and Idiopathic Gastroparesis
Grover, M., Farrugia, G., Lurken, M. S., Bernard, C. E., Faussone–Pellegrini, M. S., Smyrk, T. C., Parkman, H. P., Abell, T. L., Snape, W. J., Hasler, W. L., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.046 · Cited by 455
Camilleri, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp062614 · Cited by 329
Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes
He, C.-L., Szurszewski, J. H., Farrugia, G., Soffer, E. E., Walsh, R. M., & Ferris, C. D. (2001) · Gastroenterology · doi:10.1053/gast.2001.26264 · Cited by 320
Self-citationGastric emptying in diabetes: clinical significance and treatment
Horowitz, M., O’Donovan, D., Jones, K. L., Feinle, C., Rayner, C. K., & Samsom, M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00658.x · Cited by 308
Barañano, D. E., Ferris, C. D., & Snyder, S. H. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01716-1 · Cited by 294
Self-citationNeural roles for heme oxygenase: Contrasts to nitric oxide synthase
Barañano, D. E., & Snyder, S. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191351298 · Cited by 294
Self-citationGastric emptying and glycaemia in health and diabetes mellitus
Phillips, L. K., Deane, A. M., Jones, K. L., Rayner, C. K., & Horowitz, M. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.202 · Cited by 273
Nitric oxide in gastrointestinal health and disease
Shah, V., Lyford, G., Gores, G., & Farrugia, G. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.046 · Cited by 267
Anitha, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26295 · Cited by 258
“Insulin improves the delayed gastric emptying seen in the STZ model of diabetes at 8 weeks (12).”
BackgroundMethodInfluentialNovel Neurotransmitters and Their Neuropsychiatric Relevance
Snyder, S. H., & Ferris, C. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1738 · Cited by 262
Self-citationBharucha, A. E., Kudva, Y. C., & Prichard, D. O. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00161 · Cited by 252
Diabetes and the enteric nervous system
Chandrasekharan, B., & Srinivasan, S. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.01023.x · Cited by 243
Choi, K. M., Gibbons, S. J., Nguyen, T. V., Stoltz, G. J., Lurken, M. S., Ordog, T., Szurszewski, J. H., & Farrugia, G. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.003 · Cited by 239
Yarandi, S. S., & Srinivasan, S. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12330 · Cited by 236
Horváth, V. J., Vittal, H., Lörincz, A., Chen, H., Almeida–Porada, G., Redelman, D., & Ördög, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.027 · Cited by 228
Cell Signaling and Neuronal Death
Hara, M. R., & Snyder, S. H. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105311 · Cited by 224
Self-citationIwasaki, H., Kajimura, M., Osawa, S., Kanaoka, S., Furuta, T., Ikuma, M., & Hishida, A. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1909-8 · Cited by 190
Nitric Oxide Synthesis Is Reduced in Subjects With Type 2 Diabetes and Nephropathy
Tessari, P., Cecchet, D., Cosma, A., Vettore, M., Coracina, A., Millioni, R., Iori, E., Puricelli, L., Avogaro, A., & Vedovato, M. (2010) · Diabetes · doi:10.2337/db09-1772 · Cited by 186
“T2DM, type 2 diabetic subjects.”
InfluentialGastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting
parkman, H. P., camilleri, M., farrugia, G., mccallum, R. W., bharucha, A. E., mayer, E. A., tack, J. F., spiller, R., horowitz, M., vinik, A. I., et al. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01434.x · Cited by 192
Rivera, L. R., Poole, D. P., Thacker, M., & Furness, J. B. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01780.x · Cited by 184
Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats
Cellek, S., Foxwell, N. A., & Moncada, S. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2353 · Cited by 180
Gastroparesis: Current diagnostic challenges and management considerations
Waseem, S., Moshiree, B., & Draganov, P. V. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.25 · Cited by 175
Kanbay, M., Onal, E. M., Afşar, B., Dağel, T., Yerlikaya, A., Covic, A. C., & Vaziri, N. D. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1873-2 · Cited by 162
The Treatment of Diabetic Gastroparesis With Botulinum Toxin Injection of the Pylorus
Lacy, B. E., Crowell, M. D., Schettler-Duncan, A., Mathis, C., & Pasricha, P. J. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2341 · Cited by 147
Martinek, J., Hustak, R., Mares, J., Vackova, Z., Spicak, J., Kieslichova, E., Buncova, M., Pohl, D., Amin, S., & Tack, J. (2022) · Gut · doi:10.1136/gutjnl-2022-326904 · Cited by 137
Relationship between clinical features and gastric emptying disturbances in diabetes mellitus
Bharucha, A. E., Camilleri, M., Forstrom, L. A., & Zinsmeister, A. R. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03351.x · Cited by 146
Sanders, K. M., & Ward, S. M. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14459 · Cited by 139
“This approach was used with both streptozotocintreated and NOD mice, and the data suggest that in these models, nNOS expression is reduced, but inhibitory neurons are not (Watkins et al., 2000).”
InfluentialGastroparesis: Clinical Update. CME
Park, M.-I., & Camilleri, M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00640.x · Cited by 130
Ultrastructural differences between diabetic and idiopathic gastroparesis
Faussone‐Pellegrini, M. S., Grover, M., Pasricha, P. J., Bernard, C. E., Lurken, M. S., Smyrk, T. C., Parkman, H. P., Abell, T. L., Snape, W. J., Hasler, W. L., et al. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01451.x · Cited by 123
“This is borne out by animal studies that have shown the reversibility of the global cellular and neuromuscular or motility changes [3, 4, 29, 30].”
Micci, M., Kahrig, K. M., Simmons, R. S., Sarna, S. K., Espejo–Navarro, M. R., & Pasricha, P. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.08.055 · Cited by 124
The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications
Dal-Ros, S., & Sigrist, S. (2016) · Diseases · doi:10.3390/diseases4030024 · Cited by 128
“Moreover, nNOS, expressed also in macula densa cells and pylor, is involved in the pathogenesis of renal hemodynamic changes [227] and gastropyloric dysfunction [228] associated with diabetes.”
BackgroundNew Developments in Prokinetic Therapy for Gastric Motility Disorders
Camilleri, M., & Atieh, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.711500 · Cited by 104
“the use of sildenafil (Watkins et al., 2000), a phosphodiesterase-5 inhibitor which mimics the effect of nitric oxide by increasing intracellular cGMP.”
BackgroundActivation of TREK-1 by morphine results in analgesia without adverse side effects
Devilliers, M., Busserolles, J., Lolignier, S., Deval, E., Pereira, V., Alloui, A., Christin, M., Mazet, B., Delmas, P., Noel, J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3941 · Cited by 100
“It was expressed as the percentage of total intestinal length 65,66 .”
Vittal, H., Farrugia, G., Gomez, G., & Pasricha, P. J. (2007) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0838 · Cited by 116
“Permission obtained from the American Society for Clinical Investigation © Watkins et al. (2000)37 J Clin Invest 106: 373–384.”
BackgroundGastrointestinal Function Regulation by Nitrergic Efferent Nerves
Toda, N., & Herman, A. G. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.3.4 · Cited by 125
“Similar defects in gastric emptying were also observed in genetic and streptozotocin-elicited models of diabetes in mice; they also showed impaired nitrergic inhibitory responses of the pyloric muscle and reduced nNOS protein and mRNA in the pylorus (Watkins et al., 2000).”
BackgroundGastric Neuromuscular Pathology in Gastroparesis: Analysis of Full-Thickness Antral Biopsies
Harberson, J. J., Thomas, R. M., Harbison, S. P., & Parkman, H. P. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1071-2 · Cited by 107
“innervation. In contrast to other studies [ 3 , 5, 6], the reduction in this study was in both the nitrergic innervation and the non-nitrergic innervation.”
ResultCellek, S., Qu, W., Schmidt, A. M., & Moncada, S. (2004) · Diabetologia · doi:10.1007/s00125-003-1298-y · Cited by 108
“Previous studies have shown decreased neuronal NO synthase (nNOS) content in the pylorus and penis of diabetic animals and patients [4, 5, 8, 10, 11, 12, 13, 14].”
BackgroundGangula, P. R. R., Maner, W. L., Micci, M.-A., Garfield, R. E., & Pasricha, P. J. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00406.2006 · Cited by 103
“Several studies of animal models of diabetes have convincingly shown disturbances in enteric nerves, particularly involving nitrergic nerves (14, 49, 52).”
InfluentialNeuropathology and pathogenesis of diabetic autonomic neuropathy
Schmidt, R. E. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)50080-5 · Cited by 106
Horváth, V. J., Vittal, H., & Ördög, T. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1528 · Cited by 98
Neural stem cell therapies for enteric nervous system disorders
Burns, A. J., & Thapar, N. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.226 · Cited by 100
Regulation of interstitial cells of Cajal in the mouse gastric body by neuronal nitric oxide
Choi, K. M., Gibbons, S. J., Roeder, J. L., Lurken, M. S., Zhu, J., Wouters, M. M., Miller, S. M., Szurszewski, J. H., & Farrugia, G. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00936.x · Cited by 93
Electrogastrography: Physiological Basis and Clinical Application in Diabetic Gastropathy
Koch, K. L. (2001) · Diabetes Technology & Therapeutics · doi:10.1089/152091501750220019 · Cited by 97
Change in populations of macrophages promotes development of delayed gastric emptying in mice
Cipriani, G., Gibbons, S. J., Miller, K. E., Yang, D. S., Terhaar, M. L., Eisenman, S. T., Ördög, T., Linden, D. R., Gajdos, G. B., Szurszewski, J. H., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.02.027 · Cited by 88
Gastrointestinal Complications of Diabetes
Boland, B. S., Edelman, S. V., & Wolosin, J. D. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.006 · Cited by 96
“models of patients with diabetic gastroparesis and appears to occur early after diabetes onset.(16,17) Similarly, loss of a cytoprotective enzyme, heme oxidase-1, has been linked to the pathogenesis of gastroparesis in mouse models.”
BackgroundDiabetic Gastroparesis: Diagnosis and Management
Ma, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2009) · Drugs · doi:10.2165/00003495-200969080-00003 · Cited by 87
“Sildenafil has been reported to accelerate gastric emptying in rodent models of diabetes,([34]) but this has not been consistently Diagnosis and Management of Diabetic Gastroparesis 979”
Sildenafil citrate: A therapeutic update
Boyce, E. G., & Umland, E. M. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80027-8 · Cited by 89
Relationship Between Control of Glycemia and Gastric Emptying Disturbances in Diabetes Mellitus
Halland, M., & Bharucha, A. E. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.11.021 · Cited by 84
Advances in mechanisms of postsurgical gastroparesis syndrome and its diagnosis and treatment
Dong, K., Xiao Jiong, Y. U., Li, B., Er-gang, W., XIONG, W., & Quan Lin, G. U. A. N. (2006) · Chinese Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2006.00255.x · Cited by 84
Novel Diet, Drugs, and Gastric Interventions for Gastroparesis
Camilleri, M. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.033 · Cited by 80
“There is reduced expression of neuronal nitric oxide synthase in pylorus of nonobese diabetic mice when they develop diabetes; the reduced expression is reversed by insulin treatment.(59) In this model, the gastric emptying delay in both nonobese diabetic and streptozotocin diabetic mice was reversed with the phosphod…”
Patil, C. S., Singh, V. P., & Kulkarni, S. K. (2006) · PubMed · Cited by 79
Complex Regulation of Human Neuronal Nitric-oxide Synthase Exon 1c Gene Transcription
Saur, D., Seidler, B., Paehge, H., SCHUSDZIARRA, V., & Allescher, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109802200 · Cited by 93
Intrinsic Gastrointestinal Macrophages: Their Phenotype and Role in Gastrointestinal Motility
Cipriani, G., Gibbons, S. J., Kashyap, P. C., & Farrugia, G. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.01.003 · Cited by 77
Sivarao, D. V., Mashimo, H. L., & Goyal, R. K. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.039 · Cited by 77
Diabetes-related alterations in the enteric nervous system and its microenvironment
Bagyánszki, M. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i5.80 · Cited by 71
Izbéki, F., Wittmann, T., Rosztoczy, A. I., Linke, N., Bódi, N., Fekete, É., & Bagyánszki, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.12.013 · Cited by 78
“Since nitric oxide (NO) is considered to be an important inhibitory neurotransmitter in the gut, impairment of the nitrergic innervation in animal models of diabetes may lead to the observed motility disorders [8,9].”
BackgroundDiagnostic Assessment of Diabetic Gastroparesis
Shin, A. S., & Camilleri, M. (2013) · Diabetes · doi:10.2337/db12-1706 · Cited by 73
“, vagal) and intrinsic neuropathy, abnormalities of interstitial cells of Cajal (19–21), loss of nitric oxide synthase (22), and, possibly, myopathy (1,23).”
BackgroundInsulin resistance of amino acid and protein metabolism in type 2 diabetes
Tessari, P., Cecchet, D., Cosma, A., Puricelli, L., Millioni, R., Vedovato, M., & Tiengo, A. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.02.009 · Cited by 79
High-fat diet and age-dependent effects on enteric glial cell populations of mouse small intestine
Stenkamp-Strahm, C. M., Patterson, S., Boren, J., Gericke, M. T., & Balemba, O. B. (2013) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.04.014 · Cited by 74
“A negative secondary complication is autonomic neuropathy, often attributed to poor glucose regulation, oxidative stress, and dyslipidemia (Srinivasan et al., 2000; Watkins et al., 2000; Vincent et al., 2009; Katsilambros et al., 2011).”
BackgroundA Comprehensive Review of Neuronal Changes in Diabetics
Luna, R., Manjunatha, R. T., Bollu, B., Jhaveri, S., Avanthika, C., Reddy, N., Saha, T., & Gandhi, F. R. (2021) · Cureus · doi:10.7759/cureus.19142 · Cited by 95
“Without exception, there are significant changes in neuronal bodies [27].”
BackgroundDiagnosis and treatment of chronic gastroparesis and chronic intestinal pseudo-obstruction
Smith, D. S., Williams, C. S., & Ferris, C. D. (2003) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(03)00028-1 · Cited by 73
“The loss of NO is associated with a loss of smooth muscle relaxation [36–38] and the development of delayed gastric emptying [38].”
BackgroundInfluentialSelf-citationCurrent Concepts in Diabetic Gastroparesis
Smith, D. S., & Ferris, C. D. (2003) · Drugs · doi:10.2165/00003495-200363130-00002 · Cited by 73
Self-citationSoffer, E. E., Abell, T. L., LIN, Z., Lorincz, A., McCallum, R. W., Parkman, H. P., Policker, S., & ORDOG, T. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04082.x · Cited by 68
Non-Obese Diabetic Mice Rapidly Develop Dramatic Sympathetic Neuritic Dystrophy
Schmidt, R. E., Dorsey, D. A., Beaudet, L. N., Frederick, K. E., Parvin, C. A., Plurad, S. B., & Levisetti, M. G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63565-1 · Cited by 77
Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited?
Rayner, C. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27758 · Cited by 65
Nitrergic Enteric Neurons in Health and Disease—Focus on Animal Models
Bódi, N., Szalai, Z., & Bagyánszki, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082003 · Cited by 74
“Besides nitrergic neuronal damage, the diabetic animals represented delayed gastric emptying [29] and faster small intestinal and colonic transit compared to controls [27,33].”
BackgroundInfluentialThe Investigation and Treatment of Diabetic Gastroparesis
Kumar, M., Chapman, A., Javed, S., Alam, U., Malik, R. A., & Azmi, S. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.04.012 · Cited by 68
Recent Advances in the Pathophysiology and Treatment of Gastroparesis
Oh, J. H., & Pasricha, P. J. (2013) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2013.19.1.18 · Cited by 68
“DG was correlated with the loss of nNOS mRNA and protein.(19) Recent studies suggest that hyperlipidemia, shown to impair gastric motility functions in low-den-”
MethodZhang, H.-H., Hu, J., Zhou, Y. L., Hu, S., Wang, Y.-M., Chen, W., Xiao, Y., Huang, L.-Y. M., Jiang, X., & Xu, G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1068-13.2013 · Cited by 64
“Diabetic gastrointestinal symptoms occur in as many as 75% of DM patients (Watkins et al., 2000; Bytzer et al., 2001).”
BackgroundInfluentialCarbon monoxide reverses diabetic gastroparesis in NOD mice
Kashyap, P. C., Choi, K. M., Dutta, N., Linden, D. R., Szurszewski, J. H., Gibbons, S. J., & Farrugia, G. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00069.2010 · Cited by 61
“We focused on the changes in Kit protein in response to CO, as we and others have previously reported that, although changes in other markers, particularly nNOS expression, are observed in most models of diabetic gastroparesis (9, 17, 19, 38), it is the expression of Kit, the marker for ICC, that tracks most closely w…”
BackgroundBrzozowska, I. M., Targosz, A., Śliwowski, Z., Kwiecień, S., Drozdowicz, D., Pajdo, R., Konturek, P. C., Brzozowski, T., Pawlik, M., Konturek, S. J., et al. (2004) · PubMed · Cited by 61
Effects of diabetes on expression of glial fibrillary acidic protein and neurotrophins in rat colon
Liu, W., Yue, W., & Wu, R. (2009) · Autonomic Neuroscience · doi:10.1016/j.autneu.2009.12.003 · Cited by 66
“, 1992), sympathetic nerve damage (Camilleri and Malagelada, 1984), and damage to the enteric neurons (Watkins et al., 2000; He, 2001; Yoneda et al., 2001; Furlan et al., 2002).”
BackgroundShi, X., Chen, Z., Yang, Y., & Yan, S. (2022) · Gastroenterology Research and Practice · doi:10.1155/2022/2642551 · Cited by 67
“It is described that long-term hyperglycemia can induce disorders of the autonomic nervous system, which reduce the tension of stomach and slow gastric peristalsis, thus leading to delayed gastric emptying and abnormal gastro-pyloric-duodenal dynamics that prolong residence time of bile in the stomach and contribute t…”
BackgroundInfluence of sildenafil on gastric sensorimotor function in humans
Sarnelli, G., Sifrim, D. A., Janssens, J., & Tack, J. F. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00419.2003 · Cited by 58
“In neuronal NOS-deficient mice, gastric emptying is strongly delayed, but the role of nitric oxide in the control of gastric emptying in humans has largely remained unexplored (18, 20, 34, 43).”
BackgroundDiabetic Gastroparesis: Functional/Morphologic Background, Diagnosis, and Treatment Options
Horváth, V. J., Izbéki, F., Lengyel, C., Kempler, P., & Várkonyi, T. T. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0527-8 · Cited by 63
“In animal models, insulin therapy in a subtherapeutic dosage normalized increased stomach emptying [20].”
Plasminogen Activator Inhibitor-1 Is Involved in Streptozotocin-Induced Bone Loss in Female Mice
Tamura, Y., Kawao, N., Okada, K., Yano, M., Okumoto, K., Matsuo, O., & Kaji, H. (2013) · Diabetes · doi:10.2337/db12-1552 · Cited by 58
“Insulin was administered by subcutaneous implantation of Linbit (Linshin, Ontario, Canada) for maintaining normal blood glucose levels in the non-fasting state (<144 mg/dl) for 4 weeks after induction of diabetes in female WT mice, as previously described (14).”
MethodMacrophages in diabetic gastroparesis – the missing link?
Neshatian, L., Gibbons, S. J., & Farrugia, G. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12418 · Cited by 55
Modulatory Effect of the PDE-5 Inhibitor Sildenafil in Diabetic Neuropathy
Patil, C. S., Singh, V. P., Singh, S., & Kulkarni, S. K. (2004) · Pharmacology · doi:10.1159/000080104 · Cited by 55
Verhulst, P., Smet, B. D., Saels, I. Y., Thijs, T., Donck, L. V., Moechars, D., Peeters, T. L., & Depoortere, I. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.044 · Cited by 58
Diabetic gastroenteropathy: An underdiagnosed complication
Concepción Zavaleta, M. J., Gonzáles Yovera, J. G., Moreno Marreros, D. M., Rafael Robles, L. D. P., Palomino Taype, K. R., Soto Gálvez, K. N., Arriola Torres, L. F., Coronado Arroyo, J. C., & Concepción Urteaga, L. A. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.794 · Cited by 51
Measurement of gastric emptying in diabetes
Phillips, L. K., Rayner, C. K., Jones, K. L., & Horowitz, M. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.06.005 · Cited by 54
Anitha, M., Chandrasekharan, B. P., Rosmaninho‐Salgado, J., Grouzmann, E., Mwangi, S. M., Sitaraman, S. V., & Srinivasan, S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.019 · Cited by 53
Diabetes and cardiovascular autonomic dysfunction: Application of animal models
Angelis, K. D., Irigoyen, M. C., & Morris, M. (2008) · Autonomic Neuroscience · doi:10.1016/j.autneu.2008.10.013 · Cited by 61
“They have a short lifespan (5–8 weeks after onset of diabetic symptoms) and are difficult to study because of the rapid progression of the disease (Ordog et al., 2000;Watkins et al., 2000; Spangeus et al., 2000).”
Korenaga, K., Micci, M. ‐., Taglialatela, G., & Pasricha, P. J. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00774.x · Cited by 48
Diabetes mellitus and gastric emptying: questions and issues in clinical practice
Samsom, M., Bharucha, A., Gerich, J. E., Herrmann, K., Limmer, J., Linke, R., Maggs, D., Schirra, J., Vella, A., Wörle, H., et al. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.974 · Cited by 48
Miller, S. M., Narasimhan, R. A., Schmalz, P. F., Soffer, E. E., Walsh, R. M., Krishnamurthi, V., Pasricha, P. J., Szurszewski, J. H., & Farrugia, G. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.01040.x · Cited by 48
Determination of gastric emptying in nonobese diabetic mice
Choi, K. M., Zhu, J., Stoltz, G. J., Vernino, S., Camilleri, M., Szurszewski, J. H., Gibbons, S. J., & Farrugia, G. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00317.2007 · Cited by 49
“Treatment of diabetic mice with insulin resulted in normal gastric emptying and neuronal nitric oxide synthase (nNOS) levels (50), indicating that loss of nNOS leads to slowed gastric emptying.”
Saur, D., Neuhuber, W., Gengenbach, B., Huber, A., SCHUSDZIARRA, V., & Allescher, H. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00226.2001 · Cited by 51
“Furthermore, diabetic rats and mice with defects in gastric emptying and pyloric nonadrenergic, noncholinergic relaxation, show a profound reduction in nNOS protein and mRNA levels before neural degeneration in the pyloric sphincter (29, 36) but not in G356 DISTRIBUTION OF NNOS SPLICE VARIANTS”
BackgroundCellular pathogenesis of diabetic gastroenteropathy.
Ördög, T., Hayashi, Y., & Gibbons, S. J. (2009) · PubMed · Cited by 70
Gonlachanvit, S., Chen, Y. H., Hasler, W. L., SUN, W. M., & Owyang, C. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053421 · Cited by 47
“Finally, loss of nitric oxide function has been proposed as a cause of impaired gastric motor function in rodent models of diabetic gastroparesis (Watkins et al., 2000).”
BackgroundIncrease in neuronal nitric oxide synthase content of the gastroduodenal tract of diabetic rats
Adeghate, E. A., al-Ramadi, B. K., Saleh, A., Vijayarasathy, C., Ponery, A. S., Arafat, K., Howarth, F. C., & El-Sharkawy, T. Y. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2298-2 · Cited by 50
Characterization of myenteric neuropathy in the jejunum of spontaneously diabetic BB‐rats
Zandecki, M., Berghe, P. V., Depoortere, I., Geboes, K. J., Peeters, T. L., Janssens, J., & Tack, J. F. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01091.x · Cited by 48
DISHY, V, COHENPOUR, M., FELDMAN, L., NAFTALI, T., BAUMER, M., EFRATI, S., GOLIK, A., HORNE, T., & WEISSGARTEN, J. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.04.012 · Cited by 46
Yoneda, S., Kadowaki, M., Kuramoto, H., Fukui, H., & Takaki, M. (2001) · Autonomic Neuroscience · doi:10.1016/s1566-0702(01)00317-4 · Cited by 49
Pathophysiology, Aetiology and Treatment of Gastroparesis
Sullivan, A., Temperley, L., & Ruban, A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06287-2 · Cited by 51
“Impairment or absence of the nitric oxide pathway may therefore contribute to pylorospasm where the pylorus does not relax concurrently with antral contraction, thereby impairing GE [32, 33].”
BackgroundDemedts, I., Masaoka, T., Kindt, S., Hertogh, G. D., Geboes, K., Farré, R., Berghe, P. V., & Tack, J. (2013) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2013.19.2.161 · Cited by 43
“However, most of these studies were done in the streptozotocin or non-obese diabetic (NOD) models, and they used liquid meals or non-nutrient solids to measure emptying rate.(8,9,23) As the control of liquid emptying depends strongly on nitrergic control of pyloric motor function,(9,35,36) it is conceivable that liqui…”
BackgroundResultInfluentialDiabetic Gastroparesis and Its Impact on Glycemia
Chang, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.08.007 · Cited by 45
Metadata
- Authors
- Watkins, C. C., Sawa, A., Jaffrey, S., Blackshaw, S., Barrow, R. K., Snyder, S. H., & Ferris, C. D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Ferris, Christopher D.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-08-01
- Volume
- 106
- Issue
- 3
- Pages
- 373-384
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC314323
- OpenAlex
- W2136781148
- Cited by
- 268
- References
- 79
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 8 · 2022: 6 · 2021: 7 · 2020: 9 · 2019: 7 · 2018: 9 · 2017: 8 · 2016: 11 · 2015: 8 · 2014: 13 · 2013: 13 · 2012: 9
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (DA-00266, DA-00074)
- National Institute of Mental Health (F30MH012545)
- National Institute on Drug Abuse (P50DA000266, DA 00074, DA.00266, K05DA000074)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Surgery › Congenital gastrointestinal and neural anomalies
- Keywords
- diabetic gastropathy, neuronal nitric oxide synthase, insulin, gastric emptying, non-adrenergic non-cholinergic nerves, myenteric neurons, sildenafil, phosphodiesterase inhibition, streptozotocin-induced diabetes, NOD mice, gastrointestinal dysfunction
- MeSH terms
- Animals, Diabetes Mellitus, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1, Gastric Emptying, Humans, Insulin, Male, Mice, Inbred C57BL, Nitric Oxide, RNA, Messenger, Stomach Diseases, Gene Expression, Mice, Inbred NOD, Mice, Knockout, Nitric Oxide Synthase, Diabetes Complications, Mice, Nitric Oxide Synthase Type I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.